We are hiring!
Sandoz continues to go through an exciting and transformative period as a global leader and pioneering provider of sustainable Biosimilar and Generic medicines. As we continue down this new and ambitious path, unique opportunities will present themselves, both professionally and personally.
As a newly independent company we are focused on growth. We see growth as the engine powering everything we want to achieve for patients. It will allow us to innovate & pioneer greater access to high-quality medicines, but we can only do this by bringing the best and the brightest minds together.
As a Senior Legal Counsel, Antitrust, you will play a key role in providing strategic and operational legal support on global antitrust and competition law matters. Reporting to and supporting the Head Global Legal, Antitrust, you will play a key role in ensuring compliance with EU and international regulatory frameworks, partnering closely with business, public affairs and regulatory teams to enable compliant commercial strategies and support effective risk management across the organization. By navigating complex regulatory and policy environments and helping represent the company's interests with external stakeholders, you will contribute to protecting and advancing the business while fostering a strong culture of compliance.
Your responsibilities will include:
Antitrust & Competition Law Advisory (Strategic Partnering)
Investigations & Enforcement
Compliance & Risk Management
Minimum Requirements:
What you'll receive:
Sandoz compensation is determined by job level, qualifications, niche skills, experience, and location within company salary ranges. Fully proficient and highly effective employees can expect a starting salary around market median, with those new to the level or with less functional depth at the lower end of the range and those with sustained superior or niche skills towards the higher end of the range. Internal equity and external market data inform our range placement. Annual salary reviews consider performance outcomes, market alignment, and business needs.
Why Sandoz?
Generic and Biosimilar medicines are the backbone of the global medicines industry. Sandoz, a leader in this sector, provided more than 900 million patient treatments across 100+ countries in 2024 and while we are proud of this achievement, we have an ambition to do more!
With investments in new development capabilities, production sites, new acquisitions, and partnerships, we have the opportunity to shape the future of Sandoz and help more patients gain access to low-cost, high-quality medicines, sustainably.
Our momentum is powered by an open, collaborative culture driven by our talented and ambitious colleagues, who, in return for applying their skills experience an agile and collegiate environment with impactful, flexible-hybrid careers, where diversity is welcomed and where personal growth is supported!
Join us!
Commitment to Diversity & Inclusion:
We are committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
Hiring decisions are only based on the qualification for the position, regardless of gender, ethnicity, religion, sexual orientation, age and disability.
#Sandoz
Skills Desired
Business Development, Business Partners, Career Development, Computer Cluster, Data Privacy, Finance, Internet, Law (Legal System), Legal Advice, Litigation Law, Negotiation Skills, Private Equity, Tax

Sandoz is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for patients.
More than 20,000 people of 100 nationalities work together to ensure 900 million patient treatments are provided by Sandoz annually, generating substantial global healthcare savings and an even larger social impact. Its leading portfolio of approximately 1,300 products addresses diseases from the common cold to cancer.
Headquartered in Basel, Switzerland, Sandoz traces its heritage back to 1886. Its history of breakthroughs includes Calcium Sandoz in 1929, the world’s first oral penicillin in 1951, and the world’s first biosimilar in 2006. In 2024, Sandoz recorded net sales of USD 10.4 billion.
Read our community engagement guidelines: http://bit.ly/4ofoggc